Glycerol Phenylbutyrate Oral Liquid — FDA Drug Shortage
The FDA lists a drug shortage record for Glycerol Phenylbutyrate Oral Liquid from Amgen Inc. with status To Be Discontinued. The shortage was first posted on Sep 1, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Amgen Inc.
- Package NDC
- 75987-050-06
- Presentation
- RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-06)
- Initial Posting
- Sep 1, 2026